Translational Research to Prevent and Control Global Infectious Diseases (Translational Global Infectious Diseases Research Center, TGIR).
预防和控制全球传染病的转化研究(转化全球传染病研究中心,TGIR)。
基本信息
- 批准号:10256812
- 负责人:
- 金额:$ 165.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-15 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesAntimicrobial ResistanceBig DataBiologicalBiological SciencesBiomedical ResearchCenter for Translational Science ActivitiesCenters of Research ExcellenceCholeraClinicalClinical TrialsCollaborationsCommunicable DiseasesComplementComplexComputer ModelsCore FacilityDataData SetDevelopmentDisciplineDisease OutbreaksEpidemiologyFacultyFaculty RecruitmentFosteringGoalsGrowthHomeHumanImmunologyInfectious Diseases ResearchInterdisciplinary StudyInternationalLaboratoriesLeadMathematicsMentorsMentorshipMethodsMolecularMorbidity - disease rateParasitologyPhysiciansPopulationPopulation ResearchPreventionProgram DevelopmentResearchResearch InfrastructureResearch PersonnelResearch SupportScienceScientistSeriesStructureSystemSystems BiologyTalentsTeacher Professional DevelopmentTrainingTranslational ResearchUniversitiesVaccinesVermontWorkZIKAcareer developmentcollegedesignexperienceglobal healthimprovedinnovationinterestmembermortalitymultidisciplinarynovelnovel strategiesnovel therapeuticspredictive modelingpreventprogramsrecruitsenior facultysuccesssymposiumsynergism
项目摘要
PROJECT SUMMARY – Overall Component
Despite striking advances in the 20th and early 21st century, infectious diseases are dynamic, ever-evolving
global threats that cause significant morbidity and mortality in all populations worldwide. Within a single year,
Zika has emerged, massive outbreaks of cholera have occurred, and antimicrobial resistance has become a
critical international concern. This landscape demands new approaches to prevent and control infectious
diseases, and the training of new scientists to meet these demands. New approaches will require interpretation
of big data sets, including data from both the biologic sciences (“systems biology” and “-omics”) and advanced
epidemiology. This University of Vermont COBRE will be focused on Translational Research to Prevent and
Control Global Infectious Diseases. “The TGIR Center” (Translational Global Infectious Diseases Research)
will integrate a novel multi-disciplinary research team of biomedical and mathematical/computational scientists.
The team will work toward novel and impactful research to diminish the burden of globally-important infectious
diseases by bridging the culture gaps between the biologic and mathematical/computational fields of
biomedical research. Our center will leverage substantial existing strengths at UVM in Global Infectious
Diseases Research, and strengths in complex systems and computational modeling. A team of experienced
directors, scientific advisors/mentors, and two new core facilities (“Mathematical and Computational Predictive
Modeling” and “Human and Population Research”), will foster collaborative and novel research. The TGIR will
develop four outstanding, existing junior faculty under the mentorship of senior scientific advisors from three
UVM colleges and five departments. Institutional support will enable recruitment of three new junior faculty
and will provide space for a new Innovation and Collaboration laboratory, the latter also supported by the
proposed Alteration and Renovation component. Internal and external advisory committees will provide formal,
unbiased oversight. Junior faculty will find a robust, well-organized academic home in the TGIR COBRE: a
strong mentoring and career-development program, a center-wide seminar series and coursework, and
research support from multi-disciplinary senior faculty teams in both research cores.
项目摘要 – 总体组成部分
尽管 20 世纪和 21 世纪初取得了惊人的进步,但传染病仍然是动态的、不断演变的
全球威胁在一年内导致全世界所有人口显着发病和死亡。
寨卡病毒出现,霍乱大规模爆发,抗生素耐药性已成为一个问题
这种情况需要采取新的方法来预防和控制传染病。
疾病,以及培训新科学家以满足这些需求将需要解释。
大数据集,包括来自生物科学(“系统生物学”和“组学”)和先进科学的数据
佛蒙特州 COBRE 大学将专注于预防和预防的转化研究。
控制全球传染病。“TGIR 中心”(转化全球传染病研究)
将整合一个由生物医学和数学/计算科学家组成的新颖的多学科研究团队。
该团队将致力于新颖且有影响力的研究,以减轻全球重要传染病的负担
通过弥合生物和数学/计算领域之间的文化差距来治疗疾病
我们的中心将利用 UVM 在全球传染病领域的现有优势。
疾病研究,以及复杂系统和计算建模方面的优势。
董事、科学顾问/导师和两个新的核心设施(“数学和计算预测
建模”和“人类和人口研究”)将促进合作和新颖的研究。
在来自三个国家的高级科学顾问的指导下培养四名优秀的现有初级教师
UVM 学院和五个院系的机构支持将招募三名新的初级教师。
并将为新的创新与合作实验室提供空间,后者也得到了
拟议的改建和翻新部分将提供正式的、
初级教师将在 TGIR COBRE 找到一个强大、组织良好的学术家园:
强有力的指导和职业发展计划、中心范围的研讨会系列和课程,以及
两个研究核心的多学科高级教师团队的研究支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Beth Diane Kirkpatrick其他文献
Beth Diane Kirkpatrick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Beth Diane Kirkpatrick', 18)}}的其他基金
A Phase II Evaluation of the Safety and Protective Efficacy of the Live Attenuated Tetravalent Dengue Vaccine TetraVax-DV with Challenge by the Recombinant DENV-2 Virus in a Dengue Endemic Population
对登革热流行人群中重组 DENV-2 病毒攻击的四价登革热减毒活疫苗 TetraVax-DV 的安全性和保护效果进行 II 期评估
- 批准号:
10219920 - 财政年份:2019
- 资助金额:
$ 165.82万 - 项目类别:
A Phase II Evaluation of the Safety and Protective Efficacy of the Live Attenuated Tetravalent Dengue Vaccine TetraVax-DV with Challenge by the Recombinant DENV-2 Virus in a Dengue Endemic Population
对登革热流行人群中重组 DENV-2 病毒攻击的四价登革热减毒活疫苗 TetraVax-DV 的安全性和保护效果进行 II 期评估
- 批准号:
10673589 - 财政年份:2019
- 资助金额:
$ 165.82万 - 项目类别:
Multi-Scale Modeling of SARS-CoV-2 Dissemination Dynamics
SARS-CoV-2 传播动力学的多尺度建模
- 批准号:
10402634 - 财政年份:2018
- 资助金额:
$ 165.82万 - 项目类别:
Translational Research to Prevent and Control Global Infectious Diseases (Translational Global Infectious Diseases Research Center, TGIR).
预防和控制全球传染病的转化研究(转化全球传染病研究中心,TGIR)。
- 批准号:
10021005 - 财政年份:2018
- 资助金额:
$ 165.82万 - 项目类别:
Translational Global Infectious Diseases Research Center
转化全球传染病研究中心
- 批准号:
10706797 - 财政年份:2018
- 资助金额:
$ 165.82万 - 项目类别:
Translational Research to Prevent and Control Global Infectious Diseases (Translational Global Infectious Diseases Research Center, TGIR).
预防和控制全球传染病的转化研究(转化全球传染病研究中心,TGIR)。
- 批准号:
10853787 - 财政年份:2018
- 资助金额:
$ 165.82万 - 项目类别:
相似国自然基金
针对抗菌素耐药性的新型诊断和预防技术开发
- 批准号:82161138017
- 批准年份:2021
- 资助金额:300 万元
- 项目类别:国际(地区)合作与交流项目
牛支原体生物被膜形成相关基因的鉴定和功能研究
- 批准号:31402223
- 批准年份:2014
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Human Immunomics & Trained Immunity in Persistent Candidemia
人类免疫组学
- 批准号:
10551710 - 财政年份:2023
- 资助金额:
$ 165.82万 - 项目类别:
Metabolic Basis of Bacterial Community Function in the Cystic Fibrosis Airway
囊性纤维化气道细菌群落功能的代谢基础
- 批准号:
10416061 - 财政年份:2021
- 资助金额:
$ 165.82万 - 项目类别:
Metabolic Basis of Bacterial Community Function in the Cystic Fibrosis Airway
囊性纤维化气道细菌群落功能的代谢基础
- 批准号:
10293007 - 财政年份:2021
- 资助金额:
$ 165.82万 - 项目类别:
Metabolic Basis of Bacterial Community Function in the Cystic Fibrosis Airway
囊性纤维化气道细菌群落功能的代谢基础
- 批准号:
10624262 - 财政年份:2021
- 资助金额:
$ 165.82万 - 项目类别:
Sepsis phenotypes at risk for infections caused by multidrug resistant Gram-negative bacilli: elucidating the impact of sepsis definition and patient case mix on prediction performance
脓毒症表型面临由多重耐药革兰氏阴性杆菌引起的感染风险:阐明脓毒症定义和患者病例组合对预测性能的影响
- 批准号:
10412800 - 财政年份:2020
- 资助金额:
$ 165.82万 - 项目类别: